Management of Streptococcus mutans Infection with Patent Foramen Ovale
In patients with S. mutans infective endocarditis and a patent foramen ovale, immediate surgical intervention is indicated for valve debridement and PFO closure during the same operation, combined with appropriate antimicrobial therapy, as right-sided IE with PFO creates a pathway for systemic septic emboli including stroke. 1
Critical Clinical Context
The combination of S. mutans endocarditis and PFO represents a high-risk scenario because:
- Right-sided IE with PFO allows paradoxical embolism - septic emboli can bypass the lungs and reach systemic circulation, causing stroke or mycotic aneurysms 1
- S. mutans isolated from infected heart valves demonstrates different properties than oral strains, including altered antibiotic susceptibility and reduced adhesion characteristics 2
- Device-related endocarditis post-PFO closure has been documented with mixed S. aureus and S. pneumoniae infections, emphasizing the vulnerability of intracardiac devices to oral flora 3
Immediate Management Algorithm
1. Diagnosis and Antimicrobial Therapy
- Obtain blood cultures before initiating antibiotics 1
- Start broad-spectrum empiric coverage immediately
- Perform transesophageal echocardiography (TEE) to assess:
- Vegetation size and mobility
- Valve destruction and regurgitation severity
- Paravalvular abscess formation
- PFO size and shunt characteristics
2. Surgical Indications - Operate Early
Surgery is indicated if ANY of the following are present:
- Heart failure signs with severe valve dysfunction 1
- Large mobile vegetations (risk of embolization)
- Persistent sepsis despite 5-7 days of appropriate antibiotics 1
- Paravalvular abscess or cardiac fistulas 1
- Prosthetic valve involvement
- Evidence of systemic embolization
Do not wait for heart failure to develop - if valve regurgitation is severe enough to warrant surgery in the absence of IE, operate promptly 1
3. Surgical Approach
The operation should address both problems simultaneously:
- Radical debridement of infected valve tissue (destroyed tissue does not regrow) 1
- Valve repair or replacement as indicated
- PFO closure via direct suture during the same operation 4
- Send operative specimens for culture and pathology 1
Rationale: Closing the PFO during cardiac surgery for IE is routine practice when operating for another indication 4. This eliminates the paradoxical embolism pathway without requiring a separate percutaneous procedure.
Special Considerations for S. mutans
- S. mutans from infected valves shows reduced susceptibility to erythromycin and kanamycin compared to oral strains 2
- Adjust antibiotic therapy based on susceptibility testing
- Complete the full antimicrobial course postoperatively (typically 4-6 weeks)
- The final cure requires both antimicrobial treatment AND surgical source control 1
Post-Operative Management
- Continue appropriate antibiotics for full duration
- Monitor for recurrent bacteremia
- Emphasize dental hygiene and prophylaxis for future dental procedures
- Screen for occult sources of bacteremia
- Antiplatelet therapy as indicated for valve type
Critical Pitfalls to Avoid
- Delaying surgery while attempting prolonged medical management - S. mutans IE with complications requires surgical intervention 1
- Ignoring the PFO during IE surgery - this leaves a pathway for future paradoxical emboli
- Assuming oral antibiotic susceptibility patterns apply to valve isolates - they differ significantly 2
- Performing percutaneous PFO closure in active IE - this introduces a foreign device into an infected field 3
Multidisciplinary Team Requirements
Management requires a specialized endocarditis team including 1:
- Experienced cardiac surgeon (capable of radical debridement and reconstruction)
- Infectious disease specialist
- Cardiologist with echocardiography expertise
- Neurologist (for embolic stroke assessment)
The IE surgeon must have sufficient experience - outcomes differ widely among centers, and this carries the highest risk of any valve surgery 1